This is consistent with canonical YAP/TAZ inhibition by LATS1 in the human breast cancer setting (Zhang et al, 2008; Cordenonsi et al, 2011; Britschgi et al, 2017). This evidence concerns the gene LATS1 and breast carcinoma.